Cochrane: honey rated better for children’s cough than some OTC preps or placebo

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

April 16 2018 Honey appears likely to help children’s cough more than diphenhydramine, a...

OTC Viagra Connect availability to widen following launch via Boots

OTC Viagra Connect availability to widen following launch via Boots

April 11 2018 Viagra Connect should be available from most pharmacies at the end of this week,...

MHRA issues warning over flammability of headlice treatments

MHRA issues warning over flammability of headlice treatments

March 9 2018 Pharmacists have been asked to tell customers about the risk of fire when discussing...

OTC industry proposes maximum level for vitamin D in food supplements

OTC industry proposes maximum level for vitamin D in food supplements

March 6 2018 Food supplement manufacturers are proposing to set the maximum dose of vitamin D at...

Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

March 5 2018 There is no evidence to show any specific nutrient or food supplement affects the...

  • Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Monday, 16 April 2018 09:13
  • OTC Viagra Connect availability to widen following launch via Boots

    OTC Viagra Connect availability to widen following launch via Boots

    Wednesday, 11 April 2018 12:52
  • MHRA issues warning over flammability of headlice treatments

    MHRA issues warning over flammability of headlice treatments

    Friday, 09 March 2018 16:15
  • OTC industry proposes maximum level for vitamin D in food supplements

    OTC industry proposes maximum level for vitamin D in food supplements

    Tuesday, 06 March 2018 12:24
  • Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

    Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

    Monday, 05 March 2018 12:11

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

heart failureJune 20 2016

A warning advising of a risk of severe cardiac problems associated with people misusing loperamide have high dosage levels has been issued in the USA.

The US Food and Drug Administration has issued the warning in response to concerns about abuse and misuse of loperamide bought without prescription. Most reports of cardiac problems were reported in people using loperamide to self treat opioid withdrawal symptoms, or to achieve a feeling of euphoria.

The FDA has advised health professionals to be aware that loperamide used in higher than recommended doses is a possible cause of unexplained cardiac events. These include QT interval prolongation, Torsades de Pointes or other ventricular arryhthmias, syncope and cardiac arrest.

It has also pointed out that where loperamide is being abused, “individuals often use other drugs together with loperamide in attempts to increase its absorption and penetration across the blood-brain barrier, inhibit loperamide metabolism, and enhance its euphoric effects.”

An article in the Lancet has commented on the FDA advisory, saying that while a standard dose of loperamide for diarrhoea is 8mg in divided doses, “opioid users have been taking massive doses of the drug, as much as 300mg or more daily for weeks at a time. Although the number of reported cases is currently small, standard toxicology screenings do not look for loperamide, and it is possible that the rate of loperamide abuse is under-reported.”

Links:

FDA announcement

FDA Drug Safety Communication

Lancet 387: 10037; p2480. June 18 2016

OTC News

April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...
April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...